You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DTC

Showing 1 - 25 of 190
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hearing Loss, Hearing Loss, Sensorineural, Hearing Loss, Bilateral Trial in Chicago, Evanston (DTC Hearing Aids)

Recruiting
  • Hearing Loss
  • +2 more
  • DTC Hearing Aids
  • Chicago, Illinois
  • +1 more
May 10, 2023

Acute Ischemic Stroke Trial (perform a simultaneous bilateral DTC acquisition of 20 seconds per hemisphere)

Not yet recruiting
  • Acute Ischemic Stroke
  • perform a simultaneous bilateral DTC acquisition of 20 seconds per hemisphere
  • (no location specified)
May 2, 2023

Differentiated Thyroid Cancer (DTC), Poorly Differentiated Thyroid Cancer Trial in Philadelphia (Cabozantinib)

Active, not recruiting
  • Differentiated Thyroid Cancer (DTC)
  • Poorly Differentiated Thyroid Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Oct 7, 2021

HIV Trial in Baltimore (Ditiocarb sodium)

Completed
  • HIV Infections
  • Ditiocarb sodium
  • Baltimore, Maryland
    Johns Hopkins Adult AIDS CRS
Oct 26, 2021

Prospective, Non-interventional, Post-authorization Safety Study

Active, not recruiting
  • Thyroid Carcinoma
  • Sorafenib (Nexavar, BAY43-9006)
  • Multiple Locations, Japan
    (unnamed)
Aug 18, 2022

Clinical Significance of Circulating Tumour Cells in Resectable

Completed
  • Non Small Cell Lung Cancer
  • Circulating Tumor Cell
  • Device for CTC/DTC detection
  • Olomouc, Česká Republika, Czechia
    University Hospital Olomouc
Nov 9, 2022

Thyroid Cancer Trial in Washington (99mTc sestamibi)

Terminated
Has Results
  • Thyroid Cancer
  • 99mTc sestamibi
  • Washington, District of Columbia
    Washington Hospital Center
Jul 5, 2022

Differentiated Thyroid Cancer Trial in Leiden (rhTSH-stimulated I-124 dosimetry, Intra-therapeutic I-131 dosimetry)

Recruiting
  • Differentiated Thyroid Cancer
  • rhTSH-stimulated I-124 dosimetry
  • Intra-therapeutic I-131 dosimetry
  • Leiden, Zuid-Holland, Netherlands
    Leiden University Medical Center
Apr 8, 2022

Thyroid Cancer Trial in Beijing (Anlotinib HCl, Sodium Iodide I 131, Penpulimab)

Recruiting
  • Thyroid Cancer
  • Anlotinib hydrochloride
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Jan 18, 2022

DTC - Differentiated Thyroid Cancer Trial in Beijing (Anlotinib HCl)

Recruiting
  • DTC - Differentiated Thyroid Cancer
  • Anlotinib hydrochloride
  • Beijing, China
    Peking Union Medical College Hospital
Jan 18, 2022

CLARIFY: ADH1 and ADH2 Disease Monitoring Study (DMS)

Recruiting
  • Autosomal Dominant Hypocalcemia
    • Indianapolis, Indiana
    • +14 more
    Dec 6, 2022

    Differentiated Thyroid Cancer (DTC) Trial in China (Lenvatinib, Placebo)

    Completed
    • Differentiated Thyroid Cancer (DTC)
    • Beijing, Beijing, China
    • +23 more
    Jan 25, 2022

    Columnar Cell Variant Thyroid Gland Papillary Carcinoma, Follicular Variant Thyroid Gland Papillary Carcinoma, Metastatic

    Active, not recruiting
    • Columnar Cell Variant Thyroid Gland Papillary Carcinoma
    • +25 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Torrance, California
    • +6 more
    Jan 12, 2023

    Tracking for the Developmental Therapeutics Clinic

    Recruiting
    • Neoplasms
    • Lymphoma
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Dec 9, 2022

      Blood, Urine, and Bone Marrow

      Recruiting
      • Non Small Cell Lung Cancer
      • +5 more
      • Test for circulating tumor cells, DNA alterations
      • Columbia, Missouri
        Harry S Truman Veterans Memorial Hospital
      Oct 31, 2022

      Reminder System (TCARS) Study - A Pilot Study.

      Not yet recruiting
      • Low Risk Differentiated Thyroid Cancer
      • Shared-care model
      • (no location specified)
      Aug 18, 2022

      Thyroid Cancer Trial (20 mg Famitinib & 1200 mg Adebrelimab)

      Not yet recruiting
      • Thyroid Cancer
      • 20 mg Famitinib & 1200 mg Adebrelimab
      • (no location specified)
      Nov 26, 2023

      Differentiated Thyroid Cancer Trial in Worldwide (Dabrafenib, Trametinib, Trametinib )

      Recruiting
      • Differentiated Thyroid Cancer
      • Caba, Buenos Aires, Argentina
      • +41 more
      Nov 25, 2022

      Thyroglobulin Point of Care Assay for Rapid Detection of

      Recruiting
      • Differentiated Thyroid Cancer
      • Lymph Node Metastases
      • Point of care assay for thyroglobulin (POC-Tg) evaluation of a suspected cervical lymph node
      • Ashkelon, Israel
      • +2 more
      Oct 25, 2022

      Early Stage Breast Cancer Trial in San Francisco (Denosumab)

      Terminated
      Has Results
      • Early Stage Breast Cancer
      • San Francisco, California
        University of California San Francisco
      Dec 13, 2019

      A Taiwanese Oncogenetic Panel and Integrated Clinical Data

      Recruiting
      • Thyroid Cancer
      • A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Advanced Thyroid Cancer Patients
      • Kaohsiung, Taiwan
      • +7 more
      Sep 12, 2022

      Recurrence Score on Adjuvant Treatment Decisions in Breast

      Recruiting
      • Breast Cancer Female
        • Tübingen, BW, Germany
          Department for Women's Health
        Nov 4, 2022

        Post-Marketing Surveillance of Lenvima in Korean Patients

        Completed
        • Differentiated Thyroid Carcinoma (DTC)
          • Anyang, Gyeongji-do, Korea, Republic of
          • +31 more
          Oct 6, 2021

          Different Domains of Executive Function Dual Task Walking on

          Completed
          • Executive Function
          • Neurosciences
            • Taipei, Taiwan
              National Taiwan University Hospital
            Jun 12, 2022

            Thyroid Carcinoma Trial in Beijing, Shanghai (Surufatinib)

            Completed
            • Thyroid Carcinoma
            • Beijing, Beijing, China
            • +1 more
            Feb 12, 2020